{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:52:34Z","timestamp":1793307154087,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hereditary spastic paraplegias (HSP) are rare inherited neurodegenerative disorders characterized by progressive lower limb spasticity and weakness. This study aimed to characterize an Austrian HSP cohort and prospectively assess disease progression using the Spastic Paraplegia Rating Scale (SPRS), addressing the knowledge gap regarding its longitudinal capabilities in a real-world setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 126 patients were collected at the Center for Rare Movement Disorders Innsbruck. Baseline clinical data were available for 103 individuals. Follow-up extended up to 5 years (mean 2.3\u2009\u00b1\u20091.9). Disease severity was assessed with the SPRS, and longitudinal progression analyzed using generalized linear mixed models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort (64.3% male, mean age 47.1 years) included 54.8% patients with complicated HSP. Genetic confirmation was achieved in 54.0%, with\n                      <jats:italic>SPAST<\/jats:italic>\n                      being the most frequent genotype (36.8%). Mean baseline SPRS was 18.2 points. SPRS scores increased significantly with disease duration, with an overall annual progression of 0.9 points (p\u2009&lt;\u20090.001). Progression was faster in complicated versus pure HSP (1.3 vs. 0.6 points\/year; p\u2009&lt;\u20090.001). Most patients received symptomatic medication (69.8%) and neurorehabilitation (84.1%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides comprehensive real-world data on HSP from an Austrian cohort, including clinical, genetic, management, and imaging findings. We present the first prospective assessment of SPRS progression in a natural history cohort, revealing significant longitudinal change. Taken together, our findings may contribute to the design of future therapeutic trials in HSP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13606-y","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T13:28:16Z","timestamp":1769434096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Natural history in hereditary spastic paraplegias: real-world data from an Austrian cohort"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8786-9774","authenticated-orcid":false,"given":"Matthias","family":"Amprosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0217-8630","authenticated-orcid":false,"given":"Elisabetta","family":"Indelicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Eigentler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Boesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1342-3435","authenticated-orcid":false,"given":"Josef","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8292-3690","authenticated-orcid":false,"given":"Wolfgang","family":"Nachbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1657-7368","authenticated-orcid":false,"given":"Sylvia","family":"Boesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"1","key":"13606_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02595-4","volume":"22","author":"G Vander Stichele","year":"2022","unstructured":"Vander Stichele G, Durr A, Yoon G, Sch\u00fcle R, Blackstone C, Esposito G et al (2022) An integrated modelling methodology for estimating global incidence and prevalence of hereditary spastic paraplegia subtypes SPG4, SPG7, SPG11, and SPG15. BMC Neurol 22(1):115","journal-title":"BMC Neurol"},{"key":"13606_CR2","doi-asserted-by":"publisher","first-page":"205031212312219","DOI":"10.1177\/20503121231221941","volume":"12","author":"WA Awuah","year":"2024","unstructured":"Awuah WA, Tan JK, Shkodina AD, Ferreira T, Adebusoye FT, Mazzoleni A et al (2024) Hereditary spastic paraplegia: novel insights into the pathogenesis and management. SAGE Open Med 12:20503121231221940","journal-title":"SAGE Open Med"},{"key":"13606_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab386","author":"JL M\u00e9reaux","year":"2022","unstructured":"M\u00e9reaux JL, Banneau G, Papin M, Coarelli G, Valter R, Raymond L et al (2022) Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia. Brain. https:\/\/doi.org\/10.1093\/brain\/awab386","journal-title":"Brain"},{"issue":"4","key":"13606_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.24611","volume":"79","author":"R Sch\u00fcle","year":"2016","unstructured":"Sch\u00fcle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S et al (2016) Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol 79(4):646\u2013658","journal-title":"Ann Neurol"},{"issue":"8334","key":"13606_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"1","author":"AE Harding","year":"1983","unstructured":"Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1(8334):1151\u20131155","journal-title":"Lancet"},{"issue":"3","key":"13606_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1212\/01.wnl.0000228242.53336.90","volume":"67","author":"R Schule","year":"2006","unstructured":"Schule R, Holland-Letz T, Klimpe S, Kassubek J, Klopstock T, Mall V et al (2006) The spastic paraplegia rating scale (SPRS): a reliable and valid measure of disease severity. Neurology 67(3):430\u2013434","journal-title":"Neurology"},{"key":"13606_CR7","unstructured":"European Reference Network for Rare Neurological D. Diagnostic flowchart for hereditary spastic paraplegias (HSP\u2014suggestions for comprehensive phenotyping in HSP. Brussels: European Reference Network for Rare Neurological Diseases; 2019 2019\/02\/11"},{"issue":"Pt 6","key":"13606_CR8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/brain\/awp056","volume":"132","author":"AK Erichsen","year":"2009","unstructured":"Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM (2009) Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain 132(Pt 6):1577\u20131588","journal-title":"Brain"},{"key":"13606_CR9","unstructured":"Unesco. International standard classification of education (ISCED) 2011: UNESCO; 2012"},{"issue":"1","key":"13606_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0269-1","volume":"13","author":"EL Dong","year":"2018","unstructured":"Dong EL, Wang C, Wu S, Lu YQ, Lin XH, Su HZ et al (2018) Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China. Mol Neurodegener 13(1):36","journal-title":"Mol Neurodegener"},{"issue":"6","key":"13606_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jamaneurol.2013.1707","volume":"70","author":"P Coutinho","year":"2013","unstructured":"Coutinho P, Ruano L, Loureiro JL, Cruz VT, Barros J, Tuna A et al (2013) Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study. JAMA Neurol 70(6):746\u2013755","journal-title":"JAMA Neurol"},{"issue":"6-7","key":"13606_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neurol.2015.02.017","volume":"171","author":"S Klebe","year":"2015","unstructured":"Klebe S, Stevanin G, Depienne C (2015) Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting. Rev Neurol (Paris) 171(6\u20137):505\u2013530","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"13606_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nrl.2021.01.006","volume":"38","author":"G Ortega Suero","year":"2023","unstructured":"Ortega Suero G, Abenza Abild\u00faa MJ, Serrano Munuera C, Rouco Axpe I, Arpa Guti\u00e9rrez FJ, Adarmes G\u00f3mez AD et al (2023) Epidemiology of ataxia and hereditary spastic paraplegia in Spain: A cross-sectional study. Neurologia (Engl Ed) 38(6):379\u2013386","journal-title":"Neurologia (Engl Ed)"},{"issue":"5","key":"13606_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/cjn.2020.277","volume":"48","author":"I Haj Salem","year":"2021","unstructured":"Haj Salem I, Beaudin M, Stumpf M, Estiar MA, C\u00f4t\u00e9 PO, Brunet F et al (2021) Genetic and epidemiological study of adult ataxia and spastic paraplegia in Eastern Quebec. Can J Neurol Sci 48(5):655\u2013665","journal-title":"Can J Neurol Sci"},{"key":"13606_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.799953","volume":"12","author":"M Amprosi","year":"2021","unstructured":"Amprosi M, Indelicato E, Nachbauer W, Hussl A, Stendel C, Eigentler A et al (2021) Mast syndrome outside the amish community: SPG21 in Europe. Front Neurol 12:799953","journal-title":"Front Neurol"},{"issue":"21","key":"13606_CR16","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1212\/WNL.0000000000201374","volume":"99","author":"M Engelen","year":"2022","unstructured":"Engelen M, van Ballegoij WJC, Mallack EJ, Van Haren KP, K\u00f6hler W, Salsano E et al (2022) International recommendations for the diagnosis and management of patients with adrenoleukodystrophy. Neurology 99(21):940\u2013951","journal-title":"Neurology"},{"issue":"1","key":"13606_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000122","volume":"3","author":"N Chrestian","year":"2017","unstructured":"Chrestian N, Dupr\u00e9 N, Gan-Or Z, Szuto A, Chen S, Venkitachalam A et al (2017) Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurol Genet 3(1):e122","journal-title":"Neurol Genet"},{"issue":"1","key":"13606_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00415-018-9129-8","volume":"266","author":"SA Schneider","year":"2019","unstructured":"Schneider SA, Beckinger VE, M\u00f6ller B, Kn\u00fcpfer S, Hamann M, Deuschl G (2019) Urinary symptoms, quality of life, and patient satisfaction in genetic and sporadic hereditary spastic paraplegia. J Neurol 266(1):207\u2013211","journal-title":"J Neurol"},{"issue":"3","key":"13606_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/jnnp.2009.180331","volume":"81","author":"M Braschinsky","year":"2010","unstructured":"Braschinsky M, Zopp I, Kals M, Haldre S, Gross-Paju K (2010) Bladder dysfunction in hereditary spastic paraplegia: what to expect? J Neurol Neurosurg Psychiatry 81(3):263\u2013266","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"13606_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70003","volume":"32","author":"P Lallemant-Dudek","year":"2025","unstructured":"Lallemant-Dudek P, Guillaud-Bataille M, Hentzen C, Joussain C, Pichon B, Robain G et al (2025) Hereditary spastic paraplegias: when to expect bladder dysfunction a genetic and urodynamic study. Eur J Neurol 32(1):e70003","journal-title":"Eur J Neurol"},{"key":"13606_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00003","volume":"10","author":"M Bellofatto","year":"2019","unstructured":"Bellofatto M, De Michele G, Iovino A, Filla A, Santorelli FM (2019) Management of hereditary spastic paraplegia: a systematic review of the literature. Front Neurol 10:3","journal-title":"Front Neurol"},{"issue":"1","key":"13606_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/NRE-141196","volume":"36","author":"F Bertolucci","year":"2015","unstructured":"Bertolucci F, Di Martino S, Orsucci D, Ienco EC, Siciliano G, Rossi B et al (2015) Robotic gait training improves motor skills and quality of life in hereditary spastic paraplegia. NeuroRehabil 36(1):93\u201399","journal-title":"NeuroRehabil"},{"issue":"1","key":"13606_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200052","volume":"9","author":"M Amprosi","year":"2023","unstructured":"Amprosi M, Indelicato E, Eigentler A, Fritz J, Nachbauer W, Boesch S (2023) Toward the definition of patient-reported outcome measurements in hereditary spastic paraplegia. Neurol Genet 9(1):e200052","journal-title":"Neurol Genet"},{"key":"13606_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clineuro.2014.02.002","volume":"120","author":"D Orsucci","year":"2014","unstructured":"Orsucci D, Petrucci L, Ienco EC, Chico L, Simi P, Fogli A et al (2014) Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany. Clin Neurol Neurosurg 120:14\u201319","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"13606_CR25","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000605","volume":"7","author":"C Jordan","year":"2021","unstructured":"Jordan C, Geisel G, Alecu JE, Zhang B, Sahin M, Ebrahimi-Fakhari D (2021) Disease severity and motor impairment correlate with health-related quality of life in AP-4-associated hereditary spastic paraplegia. Neurol Genet 7(4):e605","journal-title":"Neurol Genet"},{"issue":"8","key":"13606_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16367","volume":"31","author":"AA Ibrahim","year":"2024","unstructured":"Ibrahim AA, Ollenschl\u00e4ger M, Klebe S, Sch\u00fcle R, Jeschonneck N, Kellner M et al (2024) Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia. Eur J Neurol 31(8):e16367","journal-title":"Eur J Neurol"},{"issue":"6","key":"13606_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1590\/0004-282x20160047","volume":"74","author":"KR Servelhere","year":"2016","unstructured":"Servelhere KR, Faber I, Coan AC, Fran\u00e7a M (2016) Translation and validation into Brazilian Portuguese of the spastic paraplegia rating scale (SPRS). Arq Neuropsiquiatr 74(6):489\u2013494","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"13606_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/acn3.51725","volume":"10","author":"E Loris","year":"2023","unstructured":"Loris E, Ollenschl\u00e4ger M, Greinwalder T, Eskofier B, Winkler J, Ga\u00dfner H et al (2023) Mobile digital gait analysis objectively measures progression in hereditary spastic paraplegia. Ann Clin Transl Neurol 10(3):447\u2013452","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"13606_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-03012-w","volume":"19","author":"J Malina","year":"2024","unstructured":"Malina J, Huessler EM, J\u00f6ckel KH, Boog-Whiteside E, Jeschonneck N, Schr\u00f6der B et al (2024) Development and validation of TreatHSP-QoL: a patient-reported outcome measure for health-related quality of life in hereditary spastic paraplegia. Orphanet J Rare Dis 19(1):2","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"13606_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301452","volume":"19","author":"E Diella","year":"2024","unstructured":"Diella E, D\u2019Angelo MG, Stefan C, Girardi G, Morganti R, Martinuzzi A et al (2024) Validation of the Italian version of a patient-reported outcome measure for hereditary spastic paraplegia. PLoS ONE 19(4):e0301452","journal-title":"PLoS ONE"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13606-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13606-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13606-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:01:53Z","timestamp":1773784913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13606-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13606"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13606-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to report related to the present publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. This study was approved by the institutional review board (Vote Nr: 1255\/2018). All subjects included in the prospective study provided written informed consent prior to their inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}}],"article-number":"97"}}